Northern Region Endoscopy Group

Efficacy and safety of colonoscopy in the UK NHS Bowel Cancer Screening Programme. Lee TJW, Blanks RG, Rutter MD , Moss SM , Goddard AF, Chilton A, Nickerson C, McNally RJQ, Patnick J, Rees CJ.

Colonoscopy withdrawal time and adenoma detection rate in screening colonoscopy: The optimum average withdrawal time is 10 minutes. Lee TJW, Blanks RG, Rees CJ, Wright KC, Nickerson C, Moss SM, Chilton A, Goddard AF, Patnick J, McNally RJQ , Rutter MD.

Patient and colonoscopy factors influencing adenoma detection in patients undergoing colonoscopy in the NHS Bowel Cancer Screening programme. Lee TJW, Rees CJ , Blanks RG , Moss S , Nickerson C , Wright KC , James PW , McNally RJQ , Patnick J, Rutter MD.

Association of Coloproctology 2011.

The Benefits of a Regional Collaborative Research Network: The Northern Region Endoscopy Group (NREG) experience. PT Rajasekhar, MD Rutter, CJ Rees on behalf of NREG

Bowel Cancer Screening is safe, detects earlier cancer and adenomas in 50% of cases.: experience of the prevalent round of screening from two first wave centres in the north east of England. PT Rajasekhar , GM Clifford , TJ Lee , MD Rutter , G Waddup , M Ritchie , D Nylander , J Painter, J Singh, I Ward , N Dempsey J Bowes , G Hanley, J Henry , CJ Rees.

Digestive Disease Week Chicago 2011

Efficacy and safety of colonoscopy in the UK NHS Bowel Cancer Screening Programme Lee TJW, Blanks RG , Rutter MD, Moss SM, Goddard AF, Chilton A, Nickerson C, McNally RJQ, Patnick J, Rees CJ

Colonoscopy withdrawal time and adenoma detection rate in screening colonoscopy: The optimum average withdrawal time is 10 minutes Lee TJW 1,2, Blanks RG , Rees CJ, Wright KC, Nickerson C, Moss SM, Chilton A, Goddard AF, Patnick J, McNally RJQ , Rutter MD

Patient and colonoscopy factors influencing adenoma detection in patients undergoing colonoscopy in the NHS Bowel Cancer Screening programme Lee TJW, Rees CJ 3, Blanks RG, Moss S, Nickerson C, Wright KC, James PW, McNally RJQ, Patnick J, Rutter MD

British Society of Gastroenterology 2010

Quality of ERCP services in district general hospitals in the Northern Region. D Nylander, S Chatterjee. L MacDougall, J Greenaway, D Dwarkaneth, C MacDonald, R Barton, W Gregory, C Rees. Gut 59 [Suppl.1], A 54.

Comparison of the first and second round of colorectal cancer screening in North East England. CJ Rees, M Rutter, N Dempsey, T Lee, G Waddup, M Ritchie, JN Singh, DL Nylander, J E Painter, I Ward, G M Clifford. Gut 59 [Suppl.1], A 127

A survey of Endoscopy Workload in Northern England : Lower Gastrointestinal Workload exceeds British Society of Gastroenterology Projections. TJW lee, M Rutter, C Zwart, C Rees. Gut 59 [Suppl.1], A 131

World Congress of Gastroenterology 2009

Non Neoplastic Diagnoses in the NHS Bowel Cancer Screening Programme. T. J. W. Lee*1, L. Wells1, M. Ritchie2, G. Clifford3, C. Rees3, M. D. Rutter1

Reduced stage at diagnosis of colorectal cancer in the NHS Bowel Cancer Screening programme. T. J. W. Lee*1, C. Zwart2, C. Rees2, M. D. Rutter3

A Survey of Endoscopy Workload in Northern England: Lower Gastrointestinal Endoscopy Workload Exceeds British Society of Gastroenterology Projections

T J W Lee, M D Rutter, C Zwart, C J Rees

Incidence of complications in Bowel Cancer Screening Colonoscopy is Low despite the Increased need for endoscopic therapy. D.Nylander, M. Ritchie, J. Painter, M.Rutter, L.Hurst, J.Singh, C.Rees

British Society of Gastroenterology 2009

G. Pascall*1, T. Wood2, C. Westwood1, K. Gunning2, M. Ritchie3, B. Tingle3, C. Rees3, P. M. Moncur1, A. Dhar 4. Colonic polyps are different in the UK Bowel Cancer Screening Programme (BCSP) population compared to the symptomatic population. Gut 58[Suppl.1], A121.

T J W Lee, L Hirst, D Nylander, J Painter, J Singh, C Rees, M D Rutter 1 year follow-up colonoscopies within the Bowel Cancer Screening Programme: Data from The Northern Region Endoscopy Group. Gut 58[Suppl.1], A136

T J W Lee, C Zwart, C Rees, M D Rutter. Has the introduction of the Bowel Cancer Screening Programme led to an early change in the stage of colorectal cancer at diagnosis? Gut 58[Suppl.1], A93

M C Ritchie, C M Clifford, N.J Dempsey, J Bowes, B Tingle, C J Rees. Is bowel cancer screening acceptable to patients? A review of the 30 day patient satisfaction questionnaire at 18 months. Gut 58[Suppl.1], A89

D.Nylander, M. Ritchie, J. Painter, M.Rutter, L.Hurst, J.Singh, C J.Rees. Incidence of complications in Bowel Cancer Screening Colonoscopy is low despite the Increased need for endoscopic therapy. Gut 58[Suppl.1], A85

British Society of Gastroenterology 2008

Nylander D, Rutter MD, Clifford G, Singh J, Hurst L, Painter JE, Rees,C . Adenoma detection rates are higher than predicted and correlate with colonoscopic withdrawal times in the bowel cancer screening programme [abstract]. Gut 57[Suppl.1], A93.

Pugh T, Copping W, Waddup G, Wells L, Ritchie M, Hurst L, C Rees, Rutter MD. The incidence and management of polyp cancers in the bowel cancer screening programme [abstract]. Gut 57[Suppl.1], A139.

Rees C, Ritchie M, Nylander D, Painter JE, Singh J, Waddup G, Rutter MD. Detection of early cancers by colorectal cancer screening and analysis of the presence of underlying symptoms. Gut 57[Suppl.1], A139.

Rees C, Ritchie M, Ward I, Nylander D, Painter JE, Singh J, Rutter MD. Most bowel cancer screening colonoscopies are undertaken for weak positive faecal occult blood results. Gut 57[Suppl.1], A27.

J. N. Singh*1, N. Dempsey1, M. Ritchie1, W. Copping2, L. Wells2, M. Rutter2, C. Rees3, D. Nylander4, J. Painter4. The UK National Bowel Cancer Screening Programme (BCSP):Experience over the 1st 6 months from the North East of England. Gut 57[Suppl.1], A141.